SH003 Enhances the Anti-cancer Effects of Dabrafenib on Lung Cancer Harboring BRAF G469A Mutation by Inhibiting the MAPK Signaling Pathway
Anticancer Research · 2024
DOI: 10.21873/anticanres.16992 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Yu-Jeong Choi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Preventive Medicine, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins B-raf, Imidazoles, Lung Neoplasms, Oximes. Die Arbeit wurde bisher 5-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Preventive Medicine, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea.
- Department of Korean Medicine, Graduate School, Kyung Hee University, Seoul, Republic of Korea.
- Department of Food and Biotechnology, Korea University, Sejong, Republic of Korea.
- Department of Science in Korean Medicine, Graduate School, Kyung Hee University, Seoul, Republic of Korea.
- Department of Preventive Medicine, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea; epiko@khu.ac.kr.
Zitieren
APA
Choi, Y. J., Chung, Y. H., Lee, K., Jeong, M., & Ko, S. G. (2024). SH003 Enhances the Anti-cancer Effects of Dabrafenib on Lung Cancer Harboring BRAF G469A Mutation by Inhibiting the MAPK Signaling Pathway. Anticancer Research. https://doi.org/10.21873/anticanres.16992
Vancouver
Choi YJ, Chung YH, Lee K, Jeong M, Ko SG. SH003 Enhances the Anti-cancer Effects of Dabrafenib on Lung Cancer Harboring BRAF G469A Mutation by Inhibiting the MAPK Signaling Pathway. Anticancer Research. 2024. doi:10.21873/anticanres.16992
BibTeX
@article{Choi2024,
author = {Choi, Yu-Jeong and Chung, Yoon Hey and Lee, Kangwook and Jeong, Miso and Ko, Seong-Gyu},
title = {SH003 Enhances the Anti-cancer Effects of Dabrafenib on Lung Cancer Harboring BRAF G469A Mutation by Inhibiting the MAPK Signaling Pathway},
journal = {Anticancer Research},
year = {2024},
doi = {10.21873/anticanres.16992}
}
EUVIMED